Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stryckmans

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Bone Marrow Transplantation|January 1, 1989
Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasmsA D Ho, J Thaler, R Willemze, et al.
Journal of the National Cancer Institute|September 5, 1990
Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of CancerA D Ho, J Thaler, P Stryckmans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative GroupA D Ho, J Thaler, F Mandelli, et al.
Nouvelle Revue Francaise D'Hematologie|February 1, 1993
[Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)]R Zittoun, B Rio, A Delmer, et al.
Haematology and Blood Transfusion|January 1, 1987
Therapy for adolescent and adult acute lymphoblastic leukemia: randomization of induction and consolidation therapies (preliminary results of EORTC Study 58791)P Stryckmans, J P Marie, S Suciu, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantationJ Hermans, S Suciu, T Stijnen, et al.
Annals of Hematology|August 1, 1993
Interferon in chronic myeloid leukemia. A workshop reportM Griesshammer, R Hehlmann, A Hochhaus, et al.
Leukemia|January 1, 1992
Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study GroupP Stryckmans, T De Witte, J P Marie, et al.
Leukemia|January 1, 1992
Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA GroupR Zittoun, F Mandelli, R Willemze, et al.
Seminars in Oncology|June 1, 1987
Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemiaP Stryckmans, T De Witte, N Bitar, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|January 1, 1989
Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasmsA D Ho, J Thaler, R Willemze, et al.
Journal of the National Cancer Institute|September 5, 1990
Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of CancerA D Ho, J Thaler, P Stryckmans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative GroupA D Ho, J Thaler, F Mandelli, et al.
Nouvelle Revue Francaise D'Hematologie|February 1, 1993
[Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)]R Zittoun, B Rio, A Delmer, et al.
Haematology and Blood Transfusion|January 1, 1987
Therapy for adolescent and adult acute lymphoblastic leukemia: randomization of induction and consolidation therapies (preliminary results of EORTC Study 58791)P Stryckmans, J P Marie, S Suciu, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantationJ Hermans, S Suciu, T Stijnen, et al.
Annals of Hematology|August 1, 1993
Interferon in chronic myeloid leukemia. A workshop reportM Griesshammer, R Hehlmann, A Hochhaus, et al.
Leukemia|January 1, 1992
Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study GroupP Stryckmans, T De Witte, J P Marie, et al.
Leukemia|January 1, 1992
Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA GroupR Zittoun, F Mandelli, R Willemze, et al.
Seminars in Oncology|June 1, 1987
Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemiaP Stryckmans, T De Witte, N Bitar, et al.
Pageof 14